Sabrina Khan

Sabrina Khan

Auto-generated profile, based on publicly available information

Sabrina Khan

Department of Medicine, Division of Infectious Diseases, Columbia University Irving Medical Center, 630W 168th Street, New York, NY, 10032, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2018 in Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
DFDaniel E. Freedberg
Daniel E. Freedberg
MZMargaret J. Zhou
Margaret J. Zhou
MCMargot E. Cohen
Margot E. Cohen
MAMedini K. Annavajhala
Medini K. Annavajhala
SKSabrina Khan
Sabrina Khan
JAJulian A. Abrams
Julian A. Abrams

1 March 2018 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
MGMarla J. Giddins
Marla J. Giddins
NMNenad Macesic
Nenad Macesic
MAMedini K. Annavajhala
Medini K. Annavajhala
SSStephania Stump
Stephania Stump
SKSabrina Khan
Sabrina Khan
AUAnne-Catrin Uhlemann
Anne-Catrin Uhlemann
Ceftazidime-avibactam (CAZ-AVI) is a promising novel treatment for infections caused by carbapenem-resistant Enterobacteriaceae (CRE). Despite improved treatment outcomes compared to those achieved with aminoglycoside- and colistin-based regimens, the rapid evolution of CAZ-AVI resistance during treatment has previously been reported in Klebsiella pneumoniae sequence type 258 (ST258) bla KPC-3 -harboring isolates. Here, we report the stepwise evolution and isolation of two phenotypically distinct CAZ-AVI-resistant Klebsiella pneumoniae isolates from a patient with pancreatitis. All susceptible ( n = 3) and resistant ( n = 5) isolates were of the ST307 clonal background, a rapidly emerging clone. Taking advantage of short-read Illumina and long-read Oxford Nanopore sequencing and full-length assembly of the core chromosome and plasmids, we demonstrate that CAZ-AVI resistance first occurred through a 532G → T bla KPC-2 point mutation in bla KPC-2 (D179Y protein substitution) following only 12 days of CAZ-AVI exposure. While subsequent isolates exhibited substantially decreased meropenem (MEM) MICs (≤2 μg/ml), later cultures demonstrated a second CAZ-AVI resistance phenotype with a lower CAZ-AVI MIC (12 μg/ml) but also MEM resistance (MIC > 128 μg/ml). These CAZ-AVI- and MEM-resistant isolates showed evidence of multiple genomic adaptations, mainly through insertions and deletions. This included amplification and transposition of wild-type bla KPC-2 into a novel plasmid, an IS 1 insertion upstream of ompK36 , and disruption of the rfb gene locus in these isolates. Our findings illustrate the potential of CAZ-AVI resistance to emerge in non- K. pneumoniae ST258 clonal backgrounds and alternative bla KPC variants. These results raise concerns about the strong selective pressures incurred by novel carbapenemase inhibitors, such as avibactam, on isolates previously considered invulnerable to CAZ-AVI resistance. There is an urgent need to further characterize non-KPC-mediated modes of carbapenem resistance and the intrinsic bacterial factors that facilitate the rapid emergence of resistance during treatment.

17 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MAMedini K. Annavajhala
Medini K. Annavajhala
AGAngela Gomez-Simmonds
Angela Gomez-Simmonds
NMNenad Macesic
Nenad Macesic
SSSean B. Sullivan
Sean B. Sullivan
AKAnna Kress
Anna Kress
AUAnne-Catrin Uhlemann
Anne-Catrin Uhlemann
Infections by multidrug-resistant bacteria (MDRB) remain a leading cause of morbidity and mortality after liver transplantation (LT). Gut dysbiosis characteristic of end-stage liver disease may predispose patients to intestinal MDRB colonization and infection, in turn exacerbating dysbiosis. However, relationships between MDRB colonization and dysbiosis after LT remain unclear. We prospectively recruited 177 adult patients undergoing LT at a single tertiary care center. 16 S V3-V4 rRNA sequencing was performed on 723 fecal samples collected pre-LT and periodically until one-year post-LT to test whether MDRB colonization was associated with decreased microbiome diversity. In multivariate linear mixed-effect models, MDRB colonization predicts reduced Shannon α-diversity, after controlling for underlying liver disease, antibiotic exposures, and clinical complications. Importantly, pre-LT microbial markers predict subsequent colonization by MDRB. Our results suggest MDRB colonization as a major, previously unrecognized, marker of persistent dysbiosis. Therapeutic approaches accounting for microbial and clinical factors are needed to address post-transplant microbiome health.

8 May 2017 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
STSheetal Trivedi
Sheetal Trivedi
AUAnne-Catrin Uhlemann
Anne-Catrin Uhlemann
PHPhilippe Herman-Bausier
Philippe Herman-Bausier
SSSean B Sullivan
Sean B Sullivan
MSMadeleine G Sowash
Madeleine G Sowash
FLFranklin D Lowy
Franklin D Lowy
Staphylococcus epidermidis, a major component of skin flora, is an opportunist, often causing prosthetic device infections. A family of structurally related proteins mediates staphylococcal attachment to host tissues, contributing to the success of S. epidermidis as a pathogen. We examined the ability of the surface protein SdrF to adhere to keratin, a major molecule expressed on the skin surface. A heterologous Lactococcus lactis expression system was used to express SdrF and its ligand-binding domains. Adherence to keratin types 1 and 10, human foreskin keratinocytes, and nasal epithelial cells was examined. SdrF bound human keratins 1 and 10 and adhered to keratinocytes and epithelial cells. Binding involved both the A and B domains. Anti-SdrF antibodies reduced adherence of S. epidermidis to keratin and keratinocytes. RNA interference reduced keratin synthesis in keratinocytes and, as a result, SdrF adherence. Direct force measurements using atomic force microscopy showed that SdrF mediates bacterial adhesion to keratin 10 through strong and weak bonds involving the A and B regions; strong adhesion was primarily mediated by the A region. These studies demonstrate that SdrF mediates adherence to human keratin and suggest that SdrF may facilitate S. epidermidis colonization of the skin.

1 June 2019 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
NMNenad Macesic
Nenad Macesic
SKSabrina Khan
Sabrina Khan
MGMarla J. Giddins
Marla J. Giddins
DFDaniel E. Freedberg
Daniel E. Freedberg
SWSusan Whittier
Susan Whittier
AUAnne-Catrin Uhlemann
Anne-Catrin Uhlemann
mcr-1 , a plasmid-associated gene for colistin resistance, was first described in China in 2015, but its spread in the United States is unknown. We report detection of mcr-1 -carrying Escherichia coli ST117 in a cluster of three liver transplant recipients.

1 January 2018 in Contemporary Clinical Trials
Verified
Journal Article
Closed access
AJAlexander J. Jonokuchi
Alexander J. Jonokuchi
JKJared Knopman
Jared Knopman
RRRyan E. Radwanski
Ryan E. Radwanski
MMMoises A. Martinez
Moises A. Martinez
BTBlake Eaton Samuel Taylor
Blake Eaton Samuel Taylor
ECE. Sander Connolly
E. Sander Connolly